Literature DB >> 11267959

Endoscopic evaluation of centrally located early squamous cell carcinoma of the lung.

H Nakamura1, N Kawasaki, M Hagiwara, A Ogata, H Kato.   

Abstract

BACKGROUND: Lung-sparing treatment recently has become a choice in the treatment of patients with early hilar lung carcinoma. To select the method of treatment, it is important to evaluate the histologic extent of the tumor using endoscopy.
METHODS: A total of 46 patients who underwent surgery for an endoscopically evaluated early lung carcinoma of the tracheobronchial tree were analyzed. Initial surgery was performed in 16 patients and in 30 patients surgery was performed after preoperative laser therapy. The endoscopic findings were classified into three types: superficial, nodular, and polypoid. In the resected lung, the greatest tumor dimension, the depth of mural invasion, the presence of microscopic blood and lymph vessel invasion, and metastases to the dissected lymph nodes were examined.
RESULTS: The mean greatest tumor dimensions were 14.6 +/- 7.3 mm (mean +/- standard deviation) in the nodular group, 23.3 +/- 12.8 mm in the superficial group, and 19.0 +/- 9.2 mm in the polypoid group. The greatest tumor dimension in the superficial group was significantly larger than that in the nodular group (P < 0.01). Preoperative endoscopic diagnosis of early hilar lung carcinoma was correct histologically in 34 of 46 cases (74.0%). Hilar lymph node metastases (N1), extrabronchial invasion, and extension to the peripheral bronchus were recognized in 12 cases. Complete disappearance of the tumor due to preoperative laser therapy was confirmed in eight patients. Lymph node metastasis was not found when the greatest tumor dimension measured < 8 mm. The overall absolute 5-year survival rate was 76.0% for all patients, 87.1% for the surgery alone group, and 70.0% for the surgery after preoperative laser therapy group.
CONCLUSIONS: Curative treatment of early hilar lung carcinoma is possible using photodynamic therapy alone when the tumor size is < or = 8 mm and the lesion does not extend to the peripheral bronchus. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11267959     DOI: 10.1002/1097-0142(20010315)91:6<1142::aid-cncr1110>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  BHLHE41/DEC2 Expression Induces Autophagic Cell Death in Lung Cancer Cells and Is Associated with Favorable Prognosis for Patients with Lung Adenocarcinoma.

Authors:  Toshiyuki Nagata; Kentaro Minami; Masatatsu Yamamoto; Tsubasa Hiraki; Masashi Idogawa; Katsumi Fujimoto; Shun Kageyama; Kazuhiro Tabata; Kohichi Kawahara; Kazuhiro Ueda; Ryuji Ikeda; Yukio Kato; Masaaki Komatsu; Akihide Tanimoto; Tatsuhiko Furukawa; Masami Sato
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

2.  Nodular-type central squamous cell lung carcinoma cured by intraluminal bronchoscopic treatment: A case report.

Authors:  Hikaru Aoki; Keigo Uchimura; Tatsuya Imabayashi; Yuji Matsumoto; Masahiro Higashiyama; Shun-Ichi Watanabe; Takaaki Tsuchida
Journal:  Thorac Cancer       Date:  2021-07-28       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.